Stay updated on Verubecestat Efficacy-Safety in Prodromal Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Verubecestat Efficacy-Safety in Prodromal Alzheimer's Clinical Trial page.

Latest updates to the Verubecestat Efficacy-Safety in Prodromal Alzheimer's Clinical Trial page
- Check5 days agoChange DetectedThe two screenshots show the same study record with minor layout adjustments; there are no changes to core content like eligibility criteria, primary outcomes, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check12 days agoNo Change Detected
- Check34 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference2%

- Check41 days agoChange DetectedPage updated to version v3.1.0 and removed multiple drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) with no new substantive content added.SummaryDifference0.2%

- Check55 days agoChange DetectedUpdated to v3.0.2; removed 'Back to Top'. These changes are minor and do not alter core content or functionality beyond the version label.SummaryDifference0.1%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.1%

- Check70 days agoChange DetectedThe webpage has been updated to include new information on Alzheimer's disease, including recent research and related topics, while removing some previous location details and references to genetic resources.SummaryDifference2%

Stay in the know with updates to Verubecestat Efficacy-Safety in Prodromal Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Verubecestat Efficacy-Safety in Prodromal Alzheimer's Clinical Trial page.